USPTO serial 79349852
SORTAC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 30, 2024
- Examiner
- LATTUCA, FRANK J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SORTAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JENNIFER A. VAN KIRK
JENNIFER A. VAN KIRK LEWIS ROCA ROTHGERBER CHRISTIE LLP201 East Washington StreetPhoenix, AZ 85004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biochemical preparations for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; chemical preparations for medical purposes neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; biological preparations for medical purposes for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; chemical reagents for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; medical preparations in the form of tablets, capsules, solutions, powders for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; protein synthesis inhibitors being chemical substances and compounds for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; diagnostic preparations and materials namely medical strips | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely inhalers, pumps, dispensers; Medical instruments, namely inhalers, pumps, dispensers; diagnostic, examination and monitoring equipment for medical purposes, namely medical strips; all of the aforementioned goods not relating to the field of vascular and/or cardiovascular diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Draupnir Bio ApS
- Other trademarks owned by Draupnir Bio ApS
- Other trademarks owned by Draupnir Bio ApS
- Other trademarks owned by Draupnir Bio ApS
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named SORTAC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 1, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 1, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 25, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 25, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 9, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 30, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 30, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 26, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 6, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 5, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 17, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 17, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 17, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 8, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |